Cancer Research AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 2639-2645, June 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barratt, R. A.
Right arrow Articles by Muschel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barratt, R. A.
Right arrow Articles by Muschel, R. J.

The G2 Block Induced by DNA Damage: A Caffeine-resistant Component Independent of Cdc25C, MPM-2 Phosphorylation, and H1 Kinase Activity1

Ruth A. Barratt, Gary Kao, W. Gillies McKenna, Jian Kuang and Ruth J. Muschel2

Departments of Pathology and Laboratory Medicine [R. A. B., R. J. M.] and Radiation Oncology [G. K., W. G. M.], University of Pennsylvania, Philadelphia, Pennsylvania 19104, and Department of Clinical Investigation, University of Texas M. D. Anderson Cancer Center, Houston Texas 77030 [J. K.]

Treatment of cells with agents that cause DNA damage often results in a delay in G2. There is convincing evidence showing that inhibition of p34cdc2 kinase activation is involved in the DNA damage-induced G2 delay. In this study, we have demonstrated the existence of an additional pathway, independent of the p34cdc2 kinase activation pathway, that leads to a G2 arrest in etoposide-treated cells. Both the X-ray-induced and the etoposide-induced G2 arrest were associated with inhibition of the p34cdc2 H1 kinase activation pathway as judged by p34cdc2 H1 kinase activity and phosphorylation of cdc25C. Caffeine treatment restored these activities after either of the treatments. However, the etoposide-treated cells did not resume cycling, revealing the presence of an alternative pathway leading to a G2 arrest. To explore the possibility that this additional pathway involved phosphorylation of the MPM-2 epitope that is shared by a large family of mitotic phosphoproteins, we monitored the phosphorylation status of the MPM-2 epitope after DNA damage and after treatment with caffeine. Phosphorylation of the MPM-2 epitope was depressed in both X-ray and etoposide-treated cells, and the depression was reversed by caffeine in both cases. The results indicate that the pathway affecting MPM-2 epitope phosphorylation is involved in the G2 delay caused by DNA damage. However, it is not part of the caffeine-insensitive pathway leading to a G2 block seen in etoposide-treated cells.

1 This work was supported by NIH Grants GM47439 (to R. J. M.), GM48457 (to J. K.) and training grant CA01940 (to R. A. B.).

2 To whom requests for reprints should be addressed, at Room 269 John Morgan Building, University of Pennsylvania, Philadelphia, PA 19104.

Received 12/29/97. Accepted 4/10/98.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
W. Y. Siu, A. Lau, T. Arooz, J. P.H. Chow, H. T.B. Ho, and R. Y.C. Poon
Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms
Mol. Cancer Ther., May 1, 2004; 3(5): 621 - 632.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yan, J. E. Schupp, H.-s. Hwang, M. W. Wagner, S. E. Berry, S. Strickfaden, M. L. Veigl, W. D. Sedwick, D. A. Boothman, and T. J. Kinsella
Loss of DNA Mismatch Repair Imparts Defective cdc2 Signaling and G2 Arrest Responses without Altering Survival after Ionizing Radiation
Cancer Res., November 1, 2001; 61(22): 8290 - 8297.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Sleiman and B. W. Stewart
Early Caspase Activation in Leukemic Cells Subject to Etoposide-induced G2-M Arrest: Evidence of Commitment to Apoptosis Rather Than Mitotic Cell Death
Clin. Cancer Res., September 1, 2000; 6(9): 3756 - 3765.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. J. Advani, R. Brandimarti, R. R. Weichselbaum, and B. Roizman
The Disappearance of Cyclins A and B and the Increase in Activity of the G2/M-Phase Cellular Kinase cdc2 in Herpes Simplex Virus 1-Infected Cells Require Expression of the alpha 22/US1.5 and UL13 Viral Genes
J. Virol., January 1, 2000; 74(1): 8 - 15.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. D. Kao, W. G. McKenna, and R. J. Muschel
p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells
J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.